1009 related articles for article (PubMed ID: 27094812)
1. miR-200c: a versatile watchdog in cancer progression, EMT, and drug resistance.
Mutlu M; Raza U; Saatci Ö; Eyüpoğlu E; Yurdusev E; Şahin Ö
J Mol Med (Berl); 2016 Jun; 94(6):629-44. PubMed ID: 27094812
[TBL] [Abstract][Full Text] [Related]
2. Expression of miR-9 and miR-200c, ZEB1, ZEB2 and E-cadherin in Non-Small Cell Lung Cancers in Iran.
Nourmohammadi B; Tafsiri E; Rahimi A; Nourmohammadi Z; Daneshvar Kakhaki A; Cho W; Karimipoor M
Asian Pac J Cancer Prev; 2019 Jun; 20(6):1633-1639. PubMed ID: 31244281
[TBL] [Abstract][Full Text] [Related]
3. miR-200c inhibits TGF-β-induced-EMT to restore trastuzumab sensitivity by targeting ZEB1 and ZEB2 in gastric cancer.
Zhou X; Men X; Zhao R; Han J; Fan Z; Wang Y; Lv Y; Zuo J; Zhao L; Sang M; Liu XD; Shan B
Cancer Gene Ther; 2018 May; 25(3-4):68-76. PubMed ID: 29302045
[TBL] [Abstract][Full Text] [Related]
4. Expression level of microRNA-200c is associated with cell morphology in vitro and histological differentiation through regulation of ZEB1/2 and E-cadherin in gastric carcinoma.
Kurata A; Yamada M; Ohno SI; Inoue S; Hashimoto H; Fujita K; Takanashi M; Kuroda M
Oncol Rep; 2018 Jan; 39(1):91-100. PubMed ID: 29138864
[TBL] [Abstract][Full Text] [Related]
5. Magnolol regulates miR-200c-3p to inhibit epithelial-mesenchymal transition and retinoblastoma progression by modulating the ZEB1/E-cadherin axis in vitro and in vivo.
Lai YH; Liu WL; Lee TY; Kuo CW; Liu YR; Huang CY; Chen YH; Chen IL; Wu SH; Wang SC; Lee PY; Liu CC; Lo J; Chang YC; Kuo HF; Hsieh CC; Li CY; Liu PL
Phytomedicine; 2023 Feb; 110():154597. PubMed ID: 36603340
[TBL] [Abstract][Full Text] [Related]
6. MiR-200c suppresses TGF-β signaling and counteracts trastuzumab resistance and metastasis by targeting ZNF217 and ZEB1 in breast cancer.
Bai WD; Ye XM; Zhang MY; Zhu HY; Xi WJ; Huang X; Zhao J; Gu B; Zheng GX; Yang AG; Jia LT
Int J Cancer; 2014 Sep; 135(6):1356-68. PubMed ID: 24615544
[TBL] [Abstract][Full Text] [Related]
7. Genetic dissection of the miR-200-Zeb1 axis reveals its importance in tumor differentiation and invasion.
Title AC; Hong SJ; Pires ND; Hasenöhrl L; Godbersen S; Stokar-Regenscheit N; Bartel DP; Stoffel M
Nat Commun; 2018 Nov; 9(1):4671. PubMed ID: 30405106
[TBL] [Abstract][Full Text] [Related]
8. Reduced expression of miR-200 family members contributes to antiestrogen resistance in LY2 human breast cancer cells.
Manavalan TT; Teng Y; Litchfield LM; Muluhngwi P; Al-Rayyan N; Klinge CM
PLoS One; 2013; 8(4):e62334. PubMed ID: 23626803
[TBL] [Abstract][Full Text] [Related]
9. UTMD inhibit EMT of breast cancer through the ROS/miR-200c/ZEB1 axis.
Shi D; Guo L; Sun X; Shang M; Meng D; Zhou X; Liu X; Zhao Y; Li J
Sci Rep; 2020 Apr; 10(1):6657. PubMed ID: 32313093
[TBL] [Abstract][Full Text] [Related]
10. MiR-200a negatively regulates TGF-β
Guo R; Hao G; Bao Y; Xiao J; Zhan X; Shi X; Luo L; Zhou J; Chen Q; Wei X
Am J Physiol Renal Physiol; 2018 Jun; 314(6):F1087-F1095. PubMed ID: 29357421
[TBL] [Abstract][Full Text] [Related]
11. Role of miR-200c/miR-141 in the regulation of epithelial-mesenchymal transition and migration in head and neck squamous cell carcinoma.
Tamagawa S; Beder LB; Hotomi M; Gunduz M; Yata K; Grenman R; Yamanaka N
Int J Mol Med; 2014 Apr; 33(4):879-86. PubMed ID: 24424572
[TBL] [Abstract][Full Text] [Related]
12. Copy number gain of ZEB1 mediates a double-negative feedback loop with miR-33a-5p that regulates EMT and bone metastasis of prostate cancer dependent on TGF-β signaling.
Dai Y; Wu Z; Lang C; Zhang X; He S; Yang Q; Guo W; Lai Y; Du H; Peng X; Ren D
Theranostics; 2019; 9(21):6063-6079. PubMed ID: 31534537
[No Abstract] [Full Text] [Related]
13. miR-200c enhances sensitivity of drug-resistant non-small cell lung cancer to gefitinib by suppression of PI3K/Akt signaling pathway and inhibites cell migration via targeting ZEB1.
Zhou G; Zhang F; Guo Y; Huang J; Xie Y; Yue S; Chen M; Jiang H; Li M
Biomed Pharmacother; 2017 Jan; 85():113-119. PubMed ID: 27930974
[TBL] [Abstract][Full Text] [Related]
14. microRNA-200c modulates the epithelial-to-mesenchymal transition in human renal cell carcinoma metastasis.
Wang X; Chen X; Wang R; Xiao P; Xu Z; Chen L; Hang W; Ruan A; Yang H; Zhang X
Oncol Rep; 2013 Aug; 30(2):643-50. PubMed ID: 23754305
[TBL] [Abstract][Full Text] [Related]
15. Antcin-A Modulates Epithelial-to-Mesenchymal Transition and Inhibits Migratory and Invasive Potentials of Human Breast Cancer Cells via p53-Mediated miR-200c Activation.
Kumar KJS; Vani MG; Hsieh HW; Lin CC; Wang SY
Planta Med; 2019 Jul; 85(9-10):755-765. PubMed ID: 31185503
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-200c overexpression plays an inhibitory role in human pancreatic cancer stem cells by regulating epithelial-mesenchymal transition.
Ma C; Ding YC; Yu W; Wang Q; Meng B; Huang T
Minerva Med; 2015 Aug; 106(4):193-202. PubMed ID: 26081037
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic silencing of miR-200c in breast cancer is associated with aggressiveness and is modulated by ZEB1.
Damiano V; Brisotto G; Borgna S; di Gennaro A; Armellin M; Perin T; Guardascione M; Maestro R; Santarosa M
Genes Chromosomes Cancer; 2017 Feb; 56(2):147-158. PubMed ID: 27717206
[TBL] [Abstract][Full Text] [Related]
18. Targets of miR-200c mediate suppression of cell motility and anoikis resistance.
Howe EN; Cochrane DR; Richer JK
Breast Cancer Res; 2011 Apr; 13(2):R45. PubMed ID: 21501518
[TBL] [Abstract][Full Text] [Related]
19. Astragaloside IV inhibits epithelial-mesenchymal transition and pulmonary fibrosis via lncRNA-ATB/miR-200c/ZEB1 signaling pathway.
Guan Y; Zhang J; Cai X; Cai Y; Song Z; Huang Y; Qian W; Pan Z; Zhang X
Gene; 2024 Mar; 897():148040. PubMed ID: 38065426
[TBL] [Abstract][Full Text] [Related]
20. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2.
Korpal M; Lee ES; Hu G; Kang Y
J Biol Chem; 2008 May; 283(22):14910-4. PubMed ID: 18411277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]